Skip to content
etf.net

Launched · SEC filings

Columbia Research Enhanced Value ETF

REVSNYSE ArcaB

$33.76+0.01 (+0.03%)

At close: Oct 13, 2026, 4:00 PM

B58/ 100

Rank 20 of 40 in US Value Index

B58/100Rank 20 of 40inUS Value Index
Intraday session: up, 69 prints from 33.75 to 33.76. Range 33.73 to 33.88. Use the arrow keys to read each point.33.8033.8333.8533.8810 AM12 PM2 PM4 PM
Expense ratio
0.20%
Fund size
$368M
1Y total return
+26.1%
Yield · Last 12 months
1.78%
Holdings
304
Avg volume · 30D
0M sh
NAV per share
$33.50
52W range
low $27.24high $34.55
Launched
Filings
SEC EDGAR

The ETF.net REVS Grade

B

Score 58 out of 100

Category
US Value Index⁠
Rank
20 of 40
Six-pillar profile for REVS. Scores out of 100: Cost 50, Risk 73, Mission 90, Tradability 33, Holdings 36, Durability 30. Strongest: Mission (90). Weakest: Durability (30). Leans toward Mission.

Score 58 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C50 out of 100
    Rank 19 of 40

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A90 out of 100
    Rank 11 of 37

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A73 out of 100
    Rank 9 of 39

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    D33 out of 100
    Rank 31 of 40

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D36 out of 100
    Rank 34 of 40

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    D30 out of 100
    Rank 33 of 40

Our read on REVS

ETF.net Research

BValue's oldest hazard is the stock that's cheap for a reason. REVS runs a US value universe through quality and momentum screens too, landing on roughly 300 names for 0.20% a year.

Stated mandate

The Fund seeks, before fees and expenses, to closely track the Beta Advantage Research Enhanced U.S. Value Index.

Why people hold it

  1. 01Three screens, not one: the index pairs value with quality and momentum, built to weed out the cheap-and-broken before they reach the portfolio.
  2. 02Roughly 300 holdings spread the bet wide, so one blown-up turnaround story doesn't set the tone.
  3. 03Sticks closely to the Beta Advantage Research Enhanced U.S. Value Index, so what the methodology describes is close to what you actually hold.

Worth knowing

  1. 01At 0.20%, it runs above the 0.18% category median and several times plain value beta like VTV (0.03%) or IUSV (0.04%). The screens have to earn that gap.
  2. 02Thinly traded next to the category's giants, so spreads can run wider and bigger orders take more care at the point of entry and exit.
  3. 03Cash comes back annually or semiannually, not on a monthly or quarterly drip.

REVS Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
304
Top-10 weight
34%
Largest holding
AAPL8.7%

Sectors

  • Technology23.6%
  • Financials17.7%
  • Health Care13.0%
  • Consumer Discretionary9.7%
  • Industrials8.9%
  • Consumer Staples7.3%
  • Energy6.6%
  • Real Estate3.6%
  • Communication3.4%
  • Utilities3.3%
  • Materials3.1%

Geography

  • United States98.62%
  • Ireland0.68%
  • Bermuda0.28%
  • Switzerland0.18%
  • United Kingdom0.14%
  • Puerto Rico0.09%
The fund’s holdings, weight-ordered — page 1 of 21.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001AAPLApple Inc8.74%95,513$32M715
002MSFTMicrosoft Corp7.87%54,097$29M815
003BACBank of America Corp3.33%225,155$12M439
004CVXChevron Corp2.95%51,126$11M478
005MOAltria Group Inc2.34%120,142$9M366
006METAMeta Platforms Inc2.32%11,849$9M704
007CCitigroup Inc1.83%51,988$7M408
008CSCOCisco Systems Inc1.74%54,192$6M592
009BMYBristol-Myers Squibb Co1.62%100,914$6M463
010TJXTjx Cos Inc/The1.53%40,585$6M422
011SCHWCharles Schwab Corp/The1.50%57,155$6M393
012GMGeneral Motors Co1.41%62,528$5M341
013CVSCvs Health Corp1.39%59,511$5M377
014PGRProgressive Corp/The1.35%22,752$5M390
015NEMNewmont Corp1.33%41,572$5M434

Showing 1–15 of 304 holdings

REVS Performance

Launched Sep 25, 2019

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
REVS$12,613
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. REVS $12,613. SPY $12,044. Use the arrow keys to read each point.$9,519$11,305$13,091Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for REVS. Periods over one year show the average yearly return.
PeriodREVS
Year to date+19.3%
1 month−0.2%
3 months+4.0%
1 year+26.1%
3 yearsper year+21.2%
5 yearsper year+12.9%
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for REVS
YearReturn barREVS
2026 YTD+19.3%
2025+16.8%
2024+16.4%
2023+13.5%
2022−6.2%
2021+28.5%
2020+1.5%

REVS in the news

Filtered to REVS · US Value Index

REVS Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
1.78%Last 12 months
Payout per share
$0.60Last 12 months
Last payment
$0.60 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Annual

Distribution history

2019–2026

One bar per payment. 7 payments from 2019 to 2026 YTD. Dec 20, 2019 $0.15; Dec 18, 2020 $4.67; Dec 20, 2021 $0.25; Dec 19, 2022 $0.48; Dec 18, 2023 $0.54; Dec 18, 2024 $0.47; Dec 18, 2025 $0.60. Use the arrow keys to read each point.20192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Dec 18, 2025Dec 26, 2025$0.60
Dec 18, 2024Dec 26, 2024$0.47
Dec 18, 2023Dec 26, 2023$0.54
Dec 19, 2022Dec 27, 2022$0.48
Dec 20, 2021Dec 27, 2021$0.25
Dec 18, 2020Dec 28, 2020$4.67
Dec 20, 2019Dec 26, 2019$0.15

REVS Risk

How much the fund’s monthly returns vary, scaled to a year.
12.2%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.18
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−18.1%
Trough Sep 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.77
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

REVS Cost

Expense ratio0.20%
  • The middle half of US Value Index funds
  • Median 0.20%

19 of the 40 US Value Index funds charge less.

REVS costs $20.00 a year on $10,000. The median US Value Index fund costs $20.00.

Other funds in US Value Index

See others